Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1987 Mar 1;165(3):720–732. doi: 10.1084/jem.165.3.720

Unspecific binding of group B streptococcal cocytolysin (CAMP factor) to immunoglobulins and its possible role in pathogenicity

PMCID: PMC2188285  PMID: 3546580

Abstract

The protein B of group B streptococci can bind in a nonimmune reaction to Ig of the IgG and IgM classes of various mammalian species (i.e., human, mouse, rabbit, and bovine). Protein B binding involves the Fc parts of both IgG and IgM molecules. Monoclonal or polyclonal IgG or IgM and the IgM-FC5 mu fragment of human myeloma protein combined with the protein B thereby inhibiting protein B-induced hemolysis in the CAMP reaction. The protein B/Ig complex can be dissociated with 1% Triton or guanidine-HCl (6 M). Mice infected intraperitoneally with sublethal doses of group B streptococci (GBS) and that received seven repeated intravenous injections of highly purified protein B during the first 9 h of infection developed fatal septicemia within 24 h with colony counts of up to 10(8) CFU/ml in the blood. Animals treated in the same way with either PBS or trypsinized protein B recovered. The protein B itself was not pathogenic when injected into healthy mice. Tissue sections of liver or spleen from mice infected with a lethal dose of GBS revealed the presence of protein B together with large numbers of cocci when stained by the peroxidase method using specific antibodies raised against purified protein B in the rabbit.

Full Text

The Full Text of this article is available as a PDF (885.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baker C. J., Barrett F. F., Gordon R. C., Yow M. D. Suppurative meningitis due to streptococci of Lancefield group B: a study of 33 infants. J Pediatr. 1973 Apr;82(4):724–729. doi: 10.1016/s0022-3476(73)80606-7. [DOI] [PubMed] [Google Scholar]
  2. Barton L. L., Feigin R. D., Lins R. Group B beta hemolytic streptococcal meningitis in infants. J Pediatr. 1973 Apr;82(4):719–723. doi: 10.1016/s0022-3476(73)80605-5. [DOI] [PubMed] [Google Scholar]
  3. Bayer A. S., Chow A. W., Anthony B. F., Guze L. B. Serious infections in adults due to group B streptococci. Clinical and serotypic characterization. Am J Med. 1976 Oct;61(4):498–503. doi: 10.1016/0002-9343(76)90329-6. [DOI] [PubMed] [Google Scholar]
  4. Becroft D. M., Farmer K., Mason G. H., Morris M. C., Stewart J. H. Perinatal infections by group B beta-haemolytic streptococci. Br J Obstet Gynaecol. 1976 Dec;83(12):960–966. doi: 10.1111/j.1471-0528.1976.tb00782.x. [DOI] [PubMed] [Google Scholar]
  5. Bernheimer A. W., Linder R., Avigad L. S. Nature and mechanism of action of the CAMP protein of group B streptococci. Infect Immun. 1979 Mar;23(3):838–844. doi: 10.1128/iai.23.3.838-844.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brown J., Farnsworth R., Wannamaker L. W., Johnson D. W. CAMP factor of group B streptococci: production, assay, and neutralization by sera from immunized rabbits and experimentally infected cows. Infect Immun. 1974 Feb;9(2):377–383. doi: 10.1128/iai.9.2.377-383.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. DOERY H. M., MAGNUSSON B. J., CHEYNE I. M., SULASEKHARAM J. A phospholipase in staphylococcal toxin which hydrolyses sphingomyelin. Nature. 1963 Jun 15;198:1091–1092. doi: 10.1038/1981091a0. [DOI] [PubMed] [Google Scholar]
  8. Darling C. L. Standardization and evaluation of the CAMP reaction for the prompt, presumptive identification of Streptococcus agalactiae (Lancefield group B) in clinical material. J Clin Microbiol. 1975 Feb;1(2):171–174. doi: 10.1128/jcm.1.2.171-174.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. ESSEVELD H., DANIELS-BOSMAN M. S., LEIJNSE B. Some observations about the CAMP reaction and its application to human beta haemolytic streptococci. Antonie Van Leeuwenhoek. 1958;24(2):145–156. doi: 10.1007/BF02548442. [DOI] [PubMed] [Google Scholar]
  10. Ellis S. S., Johnson A., Austin T. L. Group B streptococcal meningitis associated with otitis media. Am J Dis Child. 1976 Sep;130(9):1003–1004. doi: 10.1001/archpedi.1976.02120100093015. [DOI] [PubMed] [Google Scholar]
  11. Esseveld H., Monnier-Goudzwaard C., Van Eijk H. G., Van Soestbergen M. G. Chemical nature of a substance isolated from a group B streptococcus causing the "CAMP" reaction. Antonie Van Leeuwenhoek. 1975;41(4):449–454. doi: 10.1007/BF02565088. [DOI] [PubMed] [Google Scholar]
  12. Ferguson L., Gotoff S. P. Subdural empyema in an infant due to group B beta-hemolytic Streptococcus. Am J Dis Child. 1977 Jan;131(1):97–97. doi: 10.1001/archpedi.1977.02120140099016. [DOI] [PubMed] [Google Scholar]
  13. Forsgren A., Quie P. G. Effects of staphylococcal protein A on heat labile opsonins. J Immunol. 1974 Mar;112(3):1177–1180. [PubMed] [Google Scholar]
  14. Franciosi R. A., Knostman J. D., Zimmerman R. A. Group B streptococcal neonatal and infant infections. J Pediatr. 1973 Apr;82(4):707–718. doi: 10.1016/s0022-3476(73)80604-3. [DOI] [PubMed] [Google Scholar]
  15. Hey D. J., Hall R. T., Burry V. F., Thurn A. N. Neonatal infections caused by group B streptococci. Am J Obstet Gynecol. 1973 May 1;116(1):43–47. doi: 10.1016/0002-9378(73)90881-8. [DOI] [PubMed] [Google Scholar]
  16. Howard J. B., McCracken G. H., Jr The spectrum of group B streptococcal infections in infancy. Am J Dis Child. 1974 Dec;128(6):815–818. doi: 10.1001/archpedi.1974.02110310063011. [DOI] [PubMed] [Google Scholar]
  17. Huser H., Goeke L., Karst G., Fehrenbach F. J. Fermenter growth of Streptococcus agalactiae and large-scale production of CAMP factor. J Gen Microbiol. 1983 May;129(5):1295–1300. doi: 10.1099/00221287-129-5-1295. [DOI] [PubMed] [Google Scholar]
  18. Jürgens D., Shalaby F. Y., Fehrenbach F. J. Purification and characterization of cAMP-factor from Streptococcus agalactiae by hydrophobic interaction chromatography and chromatofocusing. J Chromatogr. 1985 Dec 4;348(2):363–370. doi: 10.1016/s0021-9673(01)92474-4. [DOI] [PubMed] [Google Scholar]
  19. Lancefield R. C. A SEROLOGICAL DIFFERENTIATION OF SPECIFIC TYPES OF BOVINE HEMOLYTIC STREPTOCOCCI (GROUP B). J Exp Med. 1934 Mar 31;59(4):441–458. doi: 10.1084/jem.59.4.441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lancefield R. C., McCarty M., Everly W. N. Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens. J Exp Med. 1975 Jul 1;142(1):165–179. doi: 10.1084/jem.142.1.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. McCracken G. H., Jr Group B streptococci: the new challenge in neonatal infections. J Pediatr. 1973 Apr;82(4):703–706. doi: 10.1016/s0022-3476(73)80603-1. [DOI] [PubMed] [Google Scholar]
  22. Myhre E. B., Kronvall G. Heterogeneity of nonimmune immunoglobulin Fc reactivity among gram-positive cocci: description of three major types of receptors for human immunoglobulin G. Infect Immun. 1977 Sep;17(3):475–482. doi: 10.1128/iai.17.3.475-482.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Patterson M. J., El Batool Hafeez A. Group B streptococci in human disease. Bacteriol Rev. 1976 Sep;40(3):774–792. doi: 10.1128/br.40.3.774-792.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Peterson G. L. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem. 1977 Dec;83(2):346–356. doi: 10.1016/0003-2697(77)90043-4. [DOI] [PubMed] [Google Scholar]
  25. Phillips E. A., Tapsall J. W., Smith D. D. Rapid tube CAMP test for identification of Streptococcus agalactiae (Lancefield group B). J Clin Microbiol. 1980 Aug;12(2):135–137. doi: 10.1128/jcm.12.2.135-137.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. ROSA U., SCASSELLATI G. A., PENNISI F. LABELLING OF HUMAN FIBRINOGEN WITH 131-I BY ELECTROLYTIC IODINATION. Biochim Biophys Acta. 1964 Jun 8;86:519–526. doi: 10.1016/0304-4165(64)90091-1. [DOI] [PubMed] [Google Scholar]
  27. Roberts K. B. Letter: Persistent group B Streptococcus bacteremia without clinical "sepsis" in infants. J Pediatr. 1976 Jun;88(6):1059–1060. doi: 10.1016/s0022-3476(76)81080-3. [DOI] [PubMed] [Google Scholar]
  28. Schalén C., Truedsson L., Christensen K. K., Christensen P. Blocking of antibody complement-dependent effector functions by streptococcal IgG Fc-receptor and staphylococcal protein A. Acta Pathol Microbiol Immunol Scand B. 1985 Dec;93(6):395–400. doi: 10.1111/j.1699-0463.1985.tb02908.x. [DOI] [PubMed] [Google Scholar]
  29. Smyth C. J., Fehrenbach F. J. Isoelectric analysis of haemolysins and enzymes from streptococci of groups A, C and G. Acta Pathol Microbiol Scand B Microbiol Immunol. 1974 Dec;82(6):860–870. doi: 10.1111/j.1699-0463.1974.tb02384.x. [DOI] [PubMed] [Google Scholar]
  30. Sternberger L. A., Hardy P. H., Jr, Cuculis J. J., Meyer H. G. The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes. J Histochem Cytochem. 1970 May;18(5):315–333. doi: 10.1177/18.5.315. [DOI] [PubMed] [Google Scholar]
  31. Sterzik B., Fehrenbach F. J. Reaction components influencing CAMP factor induced lysis. J Gen Microbiol. 1985 Apr;131(4):817–820. doi: 10.1099/00221287-131-4-817. [DOI] [PubMed] [Google Scholar]
  32. Wheeler S. M., Foley G. E. A Note on Non-Group-A Streptococci Associated with Human Infection. J Bacteriol. 1943 Oct;46(4):391–392. doi: 10.1128/jb.46.4.391-392.1943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Wilkinson H. W. Analysis of group B streptococcal types associated with disease in human infants and adults. J Clin Microbiol. 1978 Feb;7(2):176–179. doi: 10.1128/jcm.7.2.176-179.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Wilkinson H. W. CAMP-disk test for presumptive identification of group B streptococci. J Clin Microbiol. 1977 Jul;6(1):42–45. doi: 10.1128/jcm.6.1.42-45.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Wilkinson H. W., Facklam R. R., Wortham E. C. Distribution by serological type of group B streptococci isolated from a variety of clinical material over a five-year period (with special reference to neonatal sepsis and meningitis). Infect Immun. 1973 Aug;8(2):228–235. doi: 10.1128/iai.8.2.228-235.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Wilkinson H. W. Group B streptococcal infection in humans. Annu Rev Microbiol. 1978;32:41–57. doi: 10.1146/annurev.mi.32.100178.000353. [DOI] [PubMed] [Google Scholar]
  37. Wilson H. D., Eichenwald H. F. Sepsis neonatorum. Pediatr Clin North Am. 1974 Aug;21(3):571–582. doi: 10.1016/s0031-3955(16)33025-5. [DOI] [PubMed] [Google Scholar]
  38. Wiseman G. M., Caird J. D. The nature of staphylococcal beta hemolysin. I. Mode of action. Can J Microbiol. 1967 Apr;13(4):369–376. doi: 10.1139/m67-049. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES